# To Evaluate the Therapeutic Efficacy of Hydrated Amniotic Membrane in Promoting Closure of Refractory Macular Holes.

> **NCT05396209** · NA · UNKNOWN · sponsor: **Oriental Neurosurgery Evidence-Based-Study Team** · enrollment: 80 (estimated)

## Conditions studied

- Macular Holes

## Interventions

- **PROCEDURE:** Hydrated Amniotic Membrane Plug
- **PROCEDURE:** ILM filling
- **PROCEDURE:** Conventional ILM peeling

## Key facts

- **NCT ID:** NCT05396209
- **Lead sponsor:** Oriental Neurosurgery Evidence-Based-Study Team
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2024-05-15
- **Final completion:** 2025-06-15
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05396209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05396209, "To Evaluate the Therapeutic Efficacy of Hydrated Amniotic Membrane in Promoting Closure of Refractory Macular Holes.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05396209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*